PreprintCited by 32Computational Drug Discovery MethodsProtein Structure and Dynamicsvaccines and immunoinformatics approaches

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Comprehensive detection and characterization of human druggable pockets through novel binding site descriptors

Open access

Preprint — published as 10.1038/s41467-024-52146-3

Abstract

Druggable pockets are protein regions that have the ability to bind organic small molecules, and their characterization is essential in target-based drug discovery. However, strategies to derive pocket descriptors are scarce and usually exhibit limited applicability. Here, we present PocketVec, a novel approach to generate pocket descriptors for any protein binding site of interest through the inverse virtual screening of lead-like molecules. We assess the performance of our descriptors in a variety of scenarios, showing that it is on par with the best available methodologies, while overcoming some important limitations. In parallel, we systematically search for druggable pockets in the folded human proteome, using experimentally determined protein structures and AlphaFold2 models, identifying over 32,000 binding sites in more than 20,000 protein domains. Finally, we derive PocketVec descriptors for each small molecule binding site and run an all-against-all similarity search, exploring over 1.2 billion pairwise comparisons. We show how PocketVec descriptors facilitate the identification of druggable pocket similarities not revealed by structure- or sequence-based comparisons. Indeed, our analyses unveil dense clusters of similar pockets in distinct proteins for which no inhibitor has yet been crystalized, opening the door to strategies to prioritize the development of chemical probes to cover the druggable space.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/2024.03.14.584971

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 91

  1. 10.1038/s41586-023-05905-z · DOI
  2. 10.1002/pro.3730 · DOI
  3. 2019, A Structure-Based Drug Discovery Paradigm, IJMS, 20, 2783, 10.3390/ijms20112783 · DOI
  4. 10.1016/j.sbi.2017.10.010 · DOI
  5. 10.1007/s12272-015-0640-5 · DOI · Paper page
  6. 10.1038/nrd1549 · DOI
  7. 2015, Virtual screening: an in silico tool for interlacing the chemical universe with the proteome, Methods, 71, 44, 10.1016/j.ymeth.2014.08.001 · DOI
  8. 2016, Using reverse docking for target identification and its applications for drug discovery, Expert Opinion on Drug Discovery, 11, 707, 10.1080/17460441.2016.1190706 · DOI
  9. 2019, Molecular Docking: Shifting Paradigms in Drug Discovery, IJMS, 20, 4331, 10.3390/ijms20184331 · DOI
  10. 2019, An Overview of Scoring Functions Used for Protein–Ligand Interactions in Molecular Docking, Interdiscip Sci Comput Life Sci, 11, 320, 10.1007/s12539-019-00327-w · DOI
  11. Shen, C. et al. From machine learning to deep learning: Advances in scoring functions for protein– ligand docking. WIREs Comput Mol Sci 10 (2020). · DOI
  12. 10.1021/acs.jcim.8b00832 · DOI
  13. 2022, Connecting chemistry and biology through molecular descriptors, Current Opinion in Chemical Biology, 66, 102090, 10.1016/j.cbpa.2021.09.001 · DOI
  14. 10.1016/j.ymeth.2014.08.005 · DOI
  15. 2016, An overview of molecular fingerprint similarity search in virtual screening, Expert Opinion on Drug Discovery, 11, 137, 10.1517/17460441.2016.1117070 · DOI
  16. 2022, Using deep learning to annotate the protein universe, Nat Biotechnol, 40, 932, 10.1038/s41587-021-01179-w · DOI · Paper page
  17. Eguida, M. & Rognan, D . Estimating the Similarity between Protein Pockets. Int J Mol Sci 23 (2022). · DOI
  18. 10.1021/ci900349y · DOI
  19. 10.1002/prot.21858 · DOI
  20. 2020, Deciphering interaction fingerprints from protein molecular surfaces using geometric deep learning, Nat Methods, 17, 184, 10.1038/s41592-019-0666-6 · DOI
  21. 10.1021/ci3000776 · DOI
  22. 10.1021/ci300566n · DOI
  23. 10.1002/prot.24753 · DOI
  24. 10.1016/j.drudis.2018.01.039 · DOI · Paper page
  25. 10.1021/acs.jcim.9b00554 · DOI
  26. 2022, Classification of Protein-Binding Sites Using a Spherical Convolutional Neural Network, J. Chem. Inf. Model, 62, 5383, 10.1021/acs.jcim.2c00832 · DOI
  27. 10.1016/S1359-6446(04)03163-0 · DOI
  28. 2019, Binding site comparisons for target-centered drug discovery, Expert Opinion on Drug Discovery, 14, 445, 10.1080/17460441.2019.1588883 · DOI
  29. 2019, Binding site matching in rational drug design: algorithms and applications, Briefings in Bioinformatics, 20, 2167, 10.1093/bib/bby078 · DOI
  30. 2017, Computational Multitarget Drug Design, J. Chem. Inf. Model, 57, 403, 10.1021/acs.jcim.6b00491 · DOI
  31. 10.1371/journal.pone.0065894 · DOI
  32. 10.1016/j.sbi.2013.11.012 · DOI
  33. 2017, Detecting similar binding pockets to enable systems polypharmacology, PLoS Comput Biol, 13, e1005522, 10.1371/journal.pcbi.1005522 · DOI
  34. 10.1021/acs.jmedchem.6b00078 · DOI
  35. 2013, Identification of Similar Binding Sites to Detect Distant Polypharmacology, Mol. Inf, 32, 976, 10.1002/minf.201300082 · DOI
  36. 10.1016/j.pbiomolbio.2014.05.006 · DOI
  37. 10.1021/acs.jmedchem.5b02041 · DOI
  38. 2013, Identification of Distant Drug Off-Targets by Direct Superposition of Binding Pocket Surfaces, PLoS ONE, 8, e83533, 10.1371/journal.pone.0083533 · DOI
  39. 2019, Proteochemometrics – recent developments in bioactivity and selectivity modeling, Drug Discovery Today: Technologies, 32-33, 89, 10.1016/j.ddtec.2020.08.003 · DOI · Paper page
  40. 2020, Machine learning models for drug–target interactions: current knowledge and future directions, Drug Discovery Today, 25, 748, 10.1016/j.drudis.2020.03.003 · DOI
  41. 2018, A benchmark driven guide to binding site comparison: An exhaustive evaluation using tailor-made data sets (ProSPECCTs), PLoS Comput Biol, 14, e1006483, 10.1371/journal.pcbi.1006483 · DOI
  42. 2021, Artificial intelligence in drug discovery: recent advances and future perspectives, Expert Opinion on Drug Discovery, 16, 949, 10.1080/17460441.2021.1909567 · DOI · Paper page
  43. 10.1038/s41573-019-0024-5 · DOI · Paper page
  44. 2021, Highly accurate protein structure prediction for the human proteome, Nature, 596, 590, 10.1038/s41586-021-03828-1 · DOI · Paper page
  45. 10.1093/NAR/GKAB1061 · DOI · Paper page
  46. 10.1016/j.jmb.2021.167336 · DOI · Paper page
  47. 10.1038/nature03193 · DOI
  48. 10.1016/j.drudis.2006.10.005 · DOI · Paper page
  49. 2020, One molecular fingerprint to rule them all: drugs, biomolecules, and the metabolome, J Cheminform, 12, 43, 10.1186/s13321-020-00445-4 · DOI
  50. 2018, Comparative assessment of strategies to identify similar ligand-binding pockets in proteins, BMC Bioinformatics, 19, 91, 10.1186/s12859-018-2109-2 · DOI
  51. Schmidt, D. et al. Analyzing Kinase Similarity in Small Molecule and Protein Structural Space to Explore the Limits of Multi-Target Screening. Molecules 26 (2021). · DOI
  52. 2019, DeepDrug3D: Classification of ligand-binding pockets in proteins with a convolutional neural network, PLoS Comput. Biol, 15, e1006718, 10.1371/journal.pcbi.1006718 · DOI · Paper page
  53. 10.1038/sj.bjp.0707308 · DOI
  54. 10.1038/nbt1284 · DOI · Paper page
  55. 2023, Illuminating the Chemical Space of Untargeted Proteins, J Chem Inf Model, 63, 2689, 10.1021/acs.jcim.2c01364 · DOI
  56. 10.1371/journal.pcbi.1003302 · DOI
  57. 10.1021/jm0306430 · DOI · Paper page
  58. 10.1021/jm030644s · DOI
  59. 10.1371/journal.pcbi.1003571 · DOI
  60. 10.1021/ci300604z · DOI
  61. 10.1038/s41587-020-0564-6 · DOI
  62. 10.1038/s41467-021-24150-4 · DOI · Paper page
  63. 2022, Integrating and formatting biomedical data as pre-calculated knowledge graph embeddings in the Bioteque, Nat Commun, 13, 5304, 10.1038/s41467-022-33026-0 · DOI · Paper page
  64. 10.1093/NAR/GKAC1052 · DOI · Paper page
  65. 10.1093/NAR/GKAA913 · DOI · Paper page
  66. Lyu, J. , et al. AlphaFold2 structures template ligand discovery. bioRxiv (2023). · DOI
  67. 10.1186/1471-2105-10-168 · DOI
  68. 2018, P2Rank: machine learning based tool for rapid and accurate prediction of ligand binding sites from protein structure, J Cheminform, 10, 39, 10.1186/s13321-018-0285-8 · DOI
  69. 10.1038/s41573-021-00252-y · DOI
  70. 10.1016/j.phrs.2022.106552 · DOI
  71. 10.1038/nbt1358 · DOI · Paper page
  72. 10.1038/nbt.1990 · DOI · Paper page
  73. 2019, What Makes a Kinase Promiscuous for Inhibitors?, Cell Chem Biol, 26, 390, 10.1016/j.chembiol.2018.11.005 · DOI
  74. Reinecke, M. et al. Chemical proteomics reveals the target landscape of 1,000 kinase inhibitors. Nat Chem Biol (2023). · DOI
  75. 10.1016/j.drudis.2019.06.020 · DOI
  76. 2017, Detecting similar binding pockets to enable systems polypharmacology, PLoS Comput Biol, 13, e1005522, 10.1371/journal.pcbi.1005522 · DOI
  77. Jin, W. , Barzilay, R. & Jaakkola, T.S. Hierarchical Generation of Molecular Graphs using Structural Motifs. arXiv (2020).
  78. 10.1021/acs.jcim · DOI
  79. 10.1007/s10822-013-9672–4. · DOI · Paper page
  80. 2022, AI in small-molecule drug discovery: a coming wave?, Nat Rev Drug Discov, 21, 175, 10.1038/d41573-022-00025-1 · DOI · Paper page
  81. 10.1093/bioinformatics/btp163 · DOI · Paper page
  82. 2019, BioExcel Building Blocks, a software library for interoperable biomolecular simulation workflows, Sci Data, 6, 169, 10.1038/s41597-019-0177-4 · DOI
  83. 10.1006/jmbi.1998.2401 · DOI
  84. 10.1186/1758-2946-3-33 · DOI
  85. 10.1038/s41586-020-2649-2 · DOI · Paper page
  86. 10.1038/s41592-019-0686-2 · DOI · Paper page
  87. 10.1016/j.jmb.2007.01.086 · DOI
  88. 2015, The Recognition of Identical Ligands by Unrelated Proteins, ACS Chem. Biol, 10, 2772, 10.1021/acschembio.5b00683 · DOI
  89. 2022, localpdb-a Python package to manage protein structures and their annotations, Bioinformatics, 38, 2633, 10.1093/bioinformatics/btac121 · DOI
  90. 10.1093/nar/gki524 · DOI · Paper page
  91. 10.1093/nar/gkw1072 · DOI · Paper page

Metadata

Authors
Comajuncosa-Creus, A., Jorba, G., Barril, X., & Aloy, P.
Affiliations
  • Institute for Research in Biomedicine (ES)
  • Institució Catalana de Recerca i Estudis Avançats (ES)
Corresponding author
Aloy, Patrick
Venue
Nature Communications
Publisher
openRxiv
Published
2024-03-16
Volume
15
Issue
1
Pages
7917-7917
ISSN
2041-1723 (ISSN-L)
OpenAlex
W4402409899
Cited by
32
References
1
Citations by year
2026: 18 · 2025: 9 · 2024: 5
FWCI
6.77
Type
journal article
Language
en
Open access
Licence
cc-by-nc-nd
Locations
  • Nature Communications (publishedVersion, cc-by-nc-nd)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Ministerio de Ciencia, Innovación y Universidades (PID2020-119535RB-I00, PID2020)
  • Centres de Recerca de Catalunya
  • European Commission (101003633)
  • Generalitat de Catalunya (001-P-001682, 2021 SGR 00876, 001-P-001647)
  • Ministerio de Economía y Competitividad
  • Ministerio de Ciencia e Innovación (PID2020)
  • Instituto de Salud Carlos III
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
Keywords
druggable pockets, protein binding sites, human proteome, target-based drug discovery, protein-ligand binding
MeSH terms
Binding Sites, Humans, Ligands, Models, Molecular, Protein Binding, Proteins, Proteome, Drug Discovery

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review